Global Virtual Clinical Trials Market estimated close to $8 Billion (2020), is growing at above 10% CAGR

A virtual clinical trial (also known as remote/decentralized clinical trials) refers to digitally empowered clinical trial processes. The market growth is driven by growing adoption of virtual trials following outbreak of COVID-19 pandemic

Virtual trials enable easy Patient Enrolment and Remote Monitoring

Virtual trials are based on telemedicine and use dedicated apps for patient engagement and tracking. They greatly reduce the financial and time burdens. In addition, use of AI technologies can help synthesize and analyze ever-expanding data and speed up the process. Such benefits are increasingly drawing interest of life science companies/clinical trials sponsors into virtual clinical trials.

“AI likely to play important role in virtual clinical trials. Conversational AI for natural language processing (NLP) and image-based AI will increasingly become part of virtual trials. Conversational AI help maintain the patient-clinician engagement while imaging AI to play key role in trials that require radiology”  – CTO, Leading Clinical Trial Solutions Company

VC fundings increased significantly post-Covid

The number of venture capital funding deals have increased post Covid. There were six deals in 2018 which increased to 18 in 2020. Most VC funding occurred in Q3 2020 (10 deals). Notably, Medable - one of the fastest growing decentralized trials platform providers - raised $524 million from various rounds since 2020. One of the biggest rounds occurred in October 2021, where the company received a huge $304 million Series D funding. Growing VC funding will enable companies to make technological advancements and increase customer/geographic reach. This will then increase overall adoption and market growth.

Regional Overview: Global Virtual Clinical Trials Market

Comprehensive regional assessment of the global virtual clinical trials market suggests that US is currently the largest market for virtual clinical trials. On the other hand, European life science/medical device companies have not moved as rapidly to adopt virtual trials as U.S. However, there have been developments taking place in EU those are expected to propel the adoption steadily. For instance, in September 2019, the Trials@Home project was launched by the public-private partnership viz. Innovative Medicines Initiative (IMI) - to augment the use of digital tools in conduct of clinical trials. This large-scale collaborative project involves 31 members from the European Federation of Pharmaceutical Industries and Associations (EFPIA), academia, small- and mid-sized life science companies and patient organizations

Competitive Landscape Analysis: Virtual Clinical Trials Market

The key players in the global virtual clinical trials market are ICON, Parexel, IQVIA, Covance, Thermo Fisher, LEO Innovation Lab, Huma, Medidata, Oracle, CRF Health, Medable, Signant Health, and Clinical Ink.

Explore Detailed Insights on Virtual Clinical Trials Market @ https://meditechinsights.com/global-virtual-clinical-trials-market/

Comments

Post a Comment

Popular posts from this blog

Global Weight Management Market Size, Share, Analysis, Growth, Forecasts, Trends, Developments & Scope by 2027

In an era, where health and wellness have become paramount, the weight management market has experienced a significant transformation. The Weight Management Market Research Report for 2023 unveils key insights into the latest trends, innovations, and challenges facing this dynamic sector. As individuals across the globe become more conscious of their health and weight, the market is evolving to meet their diverse needs. This report provides a comprehensive overview of the weight management industry, highlighting the factors driving its growth, emerging market segments, and the strategies employed by key players to stay ahead in this competitive landscape. Growing Obesity Rate Across the World: Weight Management Market The report begins by addressing the pressing issue of the global obesity epidemic. With a focus on the alarming statistics and the societal implications of this health crisis, it establishes the context in which the weight management market operates. The report delves in...
Read more

Global Genomics Market Report Reveals Rapid Growth & Transformative Trends in the Genomic Industry by 2027

In the ever-evolving landscape of healthcare, genomics is making headlines for its groundbreaking contributions to personalized medicine, disease understanding, and advancements in pharmaceutical research. The Global Genomics Market Report for 2023 highlights the impressive growth and transformative trends within the genomics industry, shedding light on the exciting potential of genomics in shaping the future of healthcare. I. The Genomics Market Landscape The report's comprehensive analysis of the global genomics market reveals a dynamic and rapidly expanding landscape. With a CAGR of over [X]% during the forecast period, the industry is experiencing unprecedented growth. Key factors driving this growth include increased adoption of genomics in clinical diagnostics, expanding genomics research initiatives, and the development of advanced sequencing technologies. II. Personalized Medicine Revolution One of the most exciting trends highlighted in the report is the integration of ge...
Read more

Global ATMPs Consulting Market Research Report 2027 - Competitive Analysis by Size, Share, Access, Growth, Demand & Industry Solutions

Advanced therapy medicinal products (ATMPs) are medicines for human utilization which are based on genes, tissues, or cells. They provide revolutionary and novel opportunities for the treatment of diseases and injuries. ATMPs primarily target diseases with unfulfilled medical demands. It has an extensive therapeutic potential for treating multiple types of diseases such as cancer, neurodegenerative diseases, and cardiovascular diseases. Development Complexities and Regulatory Adaptations Drives the ATMPs Consulting Market Growth The development of ATMPs is a complex manufacturing process resulting from handling living tissues or generating GMOs. The huge variety of ATMPs and their inherent complexity offers analytical development challenges. Specific characterization, potency, purity, and identity assays are needed for each product. Evolving regulatory needs for ATMPs in developed regions such as EU and U.S. and the need to meet demanding regulatory expectations pose various regulator...
Read more